New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
GSK plc
GSK
Shape
US Flag

NYSE

77B

Drug Manufacturers - General

Next Earning date - 30 Oct 2024

77B

Drug Manufacturers - General

Next Earning date - 30 Oct 2024

37.52USD
Shape-0.22 ( -0.58%)
favorite-chart

Relative Strenght

76
favorite-chart

Volume Buzz

-21%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

18%

Quote Panel

Shape
Updated October 26, 2024
1W -1.68 % 1M -7.84 % 3M -5.35 % 1Y 12.64 %

Key Metrics

Shape
  • Market Cap

    76.52B


  • Shares Outstanding

    2.04B


  • Share in Float

    2.04B


  • Dividende

    1.53


  • Earning Date

    30 Oct 2024


  • Price Target

    37.52


  • Average Volume

    4.26M


  • Beta

    0.309


  • Range

    33.67-45.93


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.gsk.com


  • Sector

    Healthcare


Fundamentals

Shape

9.02x

P/E Ratio

1.88x

P/S Ratio

8.22x

P/B Ratio

1.2

Debt/Equity

12.8%

Net Margin

$2.9

EPS

How GSK compares to sector?

P/E Ratio

Relative Strength

Shape

GSK

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$33B

Shape317%

2025-Revenue

$1.47

Shape407%

2025-EPS

$9B

Shape254%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

UBS

downgrade

Previous: Not converted

2024-07-08

Now: Neutral

Goldman Sachs

initialise

Previous: Not converted

2024-05-30

Now: Neutral

SVB Leerink

upgrade

Previous: Not converted

2023-02-23

Now: Market Perform

Barclays

upgrade

Previous: Not converted

2023-02-23

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-13%

1.09
vs 1.26

Q4.22

arrow
arrow

-26%

0.64
vs 0.86

Q1.23

arrow
arrow

-17%

0.9
vs 1.09

Q2.23

arrow
arrow

+11%

0.97
vs 0.87

Q3.23

arrow
arrow

+16%

1.26
vs 1.09

Q4.23

arrow
arrow

+13%

0.72
vs 0.64

Q1.24

arrow
arrow

+21%

1.09
vs 0.9

Q2.24

arrow
arrow

+12%

1.09
vs 0.97

Q3.24

arrow
arrow

-31%

0.87
vs 1.26

Q4.24

arrow
arrow

-33%

0.48
vs 0.72

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-14%

7.8B  vs 9.1B

Q4.22

arrow
arrow

-23%

7.4B  vs 9.5B

Q1.23

arrow
arrow

-29%

7B  vs 9.8B

Q2.23

arrow
arrow

+4%

7.2B  vs 6.9B

Q3.23

arrow
arrow

+4%

8.1B  vs 7.8B

Q4.23

arrow
arrow

+9%

8.1B  vs 7.4B

Q1.24

arrow
arrow

+6%

7.4B  vs 7B

Q2.24

arrow
arrow

+10%

7.9B  vs 7.2B

Q3.24

arrow
arrow

+30%

10.6B  vs 8.1B

Q4.24

arrow
arrow

+27%

10.2B  vs 8.1B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+9%

0.09
vs 0.05

Q4.22

arrow
arrow

+14%

0.14
vs 0.09

Q1.23

arrow
arrow

+13%

0.13
vs 0.14

Q2.23

arrow
arrow

+13%

0.13
vs 0.13

Q3.23

arrow
arrow

+11%

0.11
vs 0.13

Q4.23

arrow
arrow

+3%

0.03
vs 0.11

Q1.24

arrow
arrow

+8%

0.08
vs 0.03

Q2.24

arrow
arrow

+8%

0.08
vs 0.08

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

774

774
vs 928

-17%

Q4.22

arrow
arrow

847

847
vs 774

9%

Q1.23

arrow
arrow

835

835
vs 847

-1%

Q2.23

arrow
arrow

839

839
vs 835

0%

Q3.23

arrow
arrow

864

864
vs 839

3%

Q4.23

arrow
arrow

910

910
vs 864

5%

Q1.24

arrow
arrow

926

926
vs 910

2%

Q2.24

arrow
arrow

872

872
vs 926

-6%

Earnings Growth

Latest News

GSK

schaeffersresearch.com

14 hours ago